MedTrace Logo

Postprandial Effects of Functional Bread

NCT04289545 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2021-07-19

No results posted yet for this study

Summary

This study investigates whether bread with added galactomannan, a soluble fiber, can reduce the postprandial glucose response in healthy overweight adults.

Conditions

  • Postprandial Hyperglycemia

Interventions

DIETARY_SUPPLEMENT

Functional bread

Postprandial effects of bread containing galactomannan

Sponsors & Collaborators

  • University of Bergen

    lead OTHER

Principal Investigators

  • Jutta Dierkes, PhD · University of Bergen

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2021-07-07
Completion
2021-07-07

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04289545 on ClinicalTrials.gov